No Data
No Data
The Nikkei Average started at a decrease of 160 yen with declines in Disco and Astellas Pharma, among others.
[Nikkei stock average・TOPIX (Table)]Nikkei stock average; 39965.91;-160.44TOPIX; 2860.13;-8.50[Opening summary]On the 19th, the Nikkei stock average started trading with a third consecutive loss of 160.44 yen to 39,965.91 yen. The previous day, the US stock market fell. The Dow average closed at 40,665.02 dollars, down 533.06 dollars, and the Nasdaq closed at 17,871.22, down 125.70 points. Employment and manufacturing related indicators exceeded financial estimates.
ADR Japanese stock rankings ~ overall sell-off dominated by banks including Yucho Bank, Chicago down 185 yen compared to Osaka at 40,055 yen.
ADR (American depositary receipt) Japanese stocks, compared to Tokyo Stock Exchange (converted at 1 dollar = 157.35 yen), Yucho Bank <7182>, Japan Post <6178>, SoftBank Group <9984>, Nippon Densan <6594>, Takeda Pharmaceuticals Co., Ltd. <4502>, Recruit Holdings Co., Ltd. <6098>, Fujifilm Holdings Corporation <4901>, etc. fell and overall selling pressure remained strong. Chicago Nikkei 225 futures settlement price was 40,055 yen, down 185 yen from Osaka day and night comparison. The US stock market fell. The Dow Jones Industrial Average fell 533.06 dollars to 40.
US stock market falls, wary of early rate cuts and corporate earnings (18th).
Chicago Nikkei Futures (CME) (18th) SEP24O 40310 (USD-denominated) H 40465 L 39915 C 40115, TSE ratio -125 (evening ratio +95), Vol 13268 SEP24O 40260 (JPY-denominated) H 40420 L 39865 C 40055, TSE ratio -185 (evening ratio +35), Vol 36568. American Depositary Receipt (ADR) Overview (18th) In the ADR market, compared to the Tokyo Stock Exchange (converted at 1 USD = 157.35 JPY).
The NY market fell on the 18th [NY Market Close]
[NY Dow · Nasdaq · CME (Table)] NY Dow; 40665.02; -533.06 Nasdaq; 17871.22; -125.70 CME 225; 40055; -185 (compared to TOPIX) [NY market data] The NY market fell on the 18th. The Dow Jones fell by 533.06 dollars to close at 40,665.02 dollars, and the Nasdaq closed at 17,871.22, down 125.70 points. Employment and manufacturing-related indicators exceeded financial estimates, leading to a decrease in expectations of early rate cuts.
Dr. Reddy's Laboratories to Market Takeda's Acid-Reflux Medication in India
Dr. Reddy's Laboratories (RDY) on Thursday disclosed plans to commercialize and sell Takeda Pharmaceutical's (TAK) vonoprazan tablets to treat gastroesophageal reflux disease, peptic and duodenal
Express News | Dr. Reddy's Signs Non-Exclusive Patent Licensing Agreement With Takeda To Commercialize Vonoprazan In India